Clinical Trials in Kagoshima, Japan
Locations / Kagoshima, Japan
Delta Trials hosts 854 clinical trials conducted in Kagoshima, Japan, making it a notable site of clinical research activity. These trials covering 655 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 46 trials in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Kagoshima.
854
Total Trials
655
Conditions
46
Terminated since 2020
Browse by condition (655 total)
- Crohn's disease 28 trialsAll Crohn's disease trials
- Breast cancer 28 trialsAll Breast cancer trials
- Rheumatoid arthritis 27 trialsAll Rheumatoid arthritis trials
- Ulcerative colitis 22 trialsAll Ulcerative colitis trials
- Asthma 22 trialsAll Asthma trials
- Migraine 21 trialsAll Migraine trials
- Epilepsy 16 trialsAll Epilepsy trials
- Breast neoplasms 13 trialsAll Breast neoplasms trials
- Ovarian cancer 12 trialsAll Ovarian cancer trials
- Atopic dermatitis 12 trialsAll Atopic dermatitis trials
- Colitis, ulcerative 11 trialsAll Colitis, ulcerative trials
- Arthritis, rheumatoid 10 trialsAll Arthritis, rheumatoid trials
- Metastatic breast cancer 10 trialsAll Metastatic breast cancer trials
- Type 2 diabetes mellitus 10 trialsAll Type 2 diabetes mellitus trials
- Atrial fibrillation 8 trialsAll Atrial fibrillation trials
- Fallopian tube cancer 7 trialsAll Fallopian tube cancer trials
- Plaque psoriasis 7 trialsAll Plaque psoriasis trials
- Triple negative breast cancer 6 trialsAll Triple negative breast cancer trials
- Follicular lymphoma 6 trialsAll Follicular lymphoma trials
- Partial onset seizures 6 trialsAll Partial onset seizures trials